Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Erenumab-Aooe
DRUG
3 trials
Sponsors
University of Maryland, Baltimore
, Massachusetts General Hospital
, Amgen
Conditions
Migraine
Pain, Chronic
Schwannomas
Schwannomatosis
Trigeminal Neuropathy
Phase 2
Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
Terminated
NCT05142228
University of Maryland, Baltimore
Trigeminal Neuropathy
Start: 2022-05-31
End: 2022-10-27
Updated: 2024-03-22
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Recruiting
NCT05684692
Massachusetts General Hospital
Pain, Chronic, Schwannomas, Schwannomatosis
Start: 2023-08-31
End: 2028-11-30
Target: 40
Updated: 2026-07-24
Unknown Phase
Aimovig Pregnancy Exposure Registry
Recruiting
NCT06150781
Amgen
Migraine
Start: 2021-01-27
End: 2027-10-28
Target: 2842
Updated: 2025-11-04
Related Papers
1040-E Deciphering and targeting the schwannoma-neuron-macrophage crosstalk for the treatment of schwannomatosis and associated pain
2023-10-31